Medtronic, Covidien unveil joint integration team

Covidien ($COV) and Medtronic ($MDT) announced more than 45 people will join a newly created team to tackle integration issues during their merger. The employees come from both companies. The teams are meant to preserve momentum for both Covidien and Medtronic, optimize joint operations, forward innovations and create dual solutions. More

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.